… and apoptotic vesicles, have therapeutic potential and might be used as biomarkers for
inflammatory diseases. Therefore, molecular diagnostics and targeted therapy could benefit from …

… as therapeutic targets in hematologic malignancies, autoimmune and inflammatory diseases…
the pharmacodynamic effects of specific therapeutic compounds targeting the CD30/CD30L …

… of inflammatory diseases would exceed 100; hence, this chapter will focus on conditions
where the availability of effective long-term therapy … for inflammation by the targeted delivery of …

… targeting of immune pathways in IMIDs, it was recognized that the best disease outcomes
occur when inflammation is … aggressive use of targeted therapies to control inflammation 5,20 . …

… systems for targeted treatment of inflammatory diseases. Herein … delivery systems for the
management of inflammatory diseases. … trigger for targeted therapy of inflammatory diseases. …

… treatments targeting abnormally expressed miRNAs for inflammatory … inflammatory diseases,
we provide a broad perspective on the common roles of certain miRNAs in these diseases, …

… target in inflammatory disease. Here, I discuss how this cytokine has evolved from being a
marker of inflammation to a successful target to control inflammation… of inflammatory diseases. …

… , particularly using anti-CD20 treatment, has provided proof of concept that targeting B
cells … -mediated inflammatory disease. In this review, the mechanisms of action of B cell-targeting …

… in inflammatory diseases of the airways (asthma and COPD), the intestinal tract (inflammatory
bowel diseases)… more effective therapeutic approaches for chronic inflammatory diseases. …

… lead to diseases [21,22]. S1PRs have become an attractive pharmacological target to interfere
… to various auto-immune and inflammatory diseases; the discovery of fingolimod and its …